We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$49.2B
AUM Growth
-$3.11B
Cap. Flow
-$91.1M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.77%
Holding
2,288
New
88
Increased
463
Reduced
591
Closed
79

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Healthcare 15.91%
3 Financials 13.97%
4 Consumer Discretionary 9.85%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
2101
Rhythm Pharmaceuticals
RYTM
$7.49B
$59K ﹤0.01%
5,090
GTHX
2102
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$59K ﹤0.01%
7,740
KNTE
2103
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$59K ﹤0.01%
5,263
-9,737
-65% -$107K
NEX
2104
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$59K ﹤0.01%
+6,420
New +$46K
RXDX
2105
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$59K ﹤0.01%
+1,560
New +$61.7K
RUBY
2106
DELISTED
Rubius Therapeutics, Inc
RUBY
$58K ﹤0.01%
10,560
GBIO
2107
DELISTED
Generation Bio
GBIO
$57K ﹤0.01%
779
MDXG icon
2108
MiMedx Group
MDXG
$652M
$57K ﹤0.01%
12,070
ONTF
2109
DELISTED
ON24
ONTF
$57K ﹤0.01%
4,350
+4,250
+4,250% +$63.9K
HUMA icon
2110
Humacyte
HUMA
$174M
$56K ﹤0.01%
+7,940
New +$46.2K
PRLD icon
2111
Prelude Therapeutics
PRLD
$358M
$56K ﹤0.01%
8,080
ORIC icon
2112
Oric Pharmaceuticals
ORIC
$1.22B
$55K ﹤0.01%
10,360
GPK icon
2113
Graphic Packaging
GPK
$3.45B
$54K ﹤0.01%
2,670
-52,850
-95% -$1.03M
SSB icon
2114
SouthState Bank Corp
SSB
$10.3B
$54K ﹤0.01%
+660
New +$56.9K
ZYME icon
2115
Zymeworks
ZYME
$1.66B
$54K ﹤0.01%
8,270
SYRS
2116
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$54K ﹤0.01%
4,500
PAYO icon
2117
Payoneer
PAYO
$2.41B
$53K ﹤0.01%
+11,970
New +$60.5K
AVID
2118
DELISTED
Avid Technology Inc
AVID
$53K ﹤0.01%
1,530
LTCH
2119
DELISTED
Latch, Inc. Common Stock
LTCH
$53K ﹤0.01%
+12,440
New +$65K
XPEL icon
2120
XPEL
XPEL
$1.22B
$52K ﹤0.01%
990
YMAB
2121
DELISTED
Y-mAbs Therapeutics
YMAB
$52K ﹤0.01%
4,340
VLTA
2122
DELISTED
Volta Inc.
VLTA
$52K ﹤0.01%
+16,940
New +$81.4K
OZON
2123
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$52K ﹤0.01%
2,750
BOLT icon
2124
Bolt Biotherapeutics
BOLT
$7.67M
$51K ﹤0.01%
925
CUE icon
2125
Cue Biopharma
CUE
$132M
$51K ﹤0.01%
347

Similar funds

Ensign Peak Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Ensign Peak Advisors held 2,288 positions worth $49.2B, down 5.9% from $52.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q1 2022 filing shows 88 new, 463 increased, 591 reduced and 79 closed positions. Its largest new stake was Constellation Energy: 260,204 shares worth $14.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2022 buy was Constellation Energy: 260,204 shares worth $14.6M.
  • Ensign Peak Advisors added most to iShares Russell 2000 ETF in Q1 2022, an estimated $261M increase.
  • Ensign Peak Advisors's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Ensign Peak Advisors fully exited Athene Holding Ltd. Class A Common Shares in Q1 2022, selling an estimated $64.3M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $49.2B portfolio in Q1 2022.
  • Ensign Peak Advisors opened 88 new positions and closed 79 in Q1 2022.
  • Ensign Peak Advisors's portfolio value fell 5.9% quarter-over-quarter to $49.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.